http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003530185-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2007-126
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F7-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F7-12
filingDate 2001-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2003-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2003530185-A
titleOfInvention Medical law
abstract (57) Abstract Intravascular cooling devices are used to provide hypothermia as a medical procedure. As an example, a coronary artery bypass procedure is performed, the patient's blood is oxygenated in the patient's lungs, and the blood is circulated by the patient's heart or internal pump. This procedure involves (a) placing a heat transfer device in the patient's blood vessel, (b) cooling the patient's body to 35 ° C. or less, preferably 32 ± 2 ° C., (c) the arterial blood supply and the coronary artery. And linking between. Thereafter, the patient's body is warmed to 37 ° C. using a heat transfer device. Alternatively, the hypothermic treatment is administered when the patient is awake or semi-awake. The procedure involves (a) administering a beta blocker to the patient, (b) inserting a heat transfer device into the patient's blood vessels, and (c) cooling the patient's whole or partial area to 35 ° C. or less. In another example, the method comprises (a) providing a hypothermic condition to a patient suffering from ischemic neurological symptoms, (i) inserting a heat transfer device into the patient's blood vessels, and (ii) whole or partial. Is cooled to 35 ° C. or lower, and a therapeutic agent selected from (b) (i) a free radical detergent, (ii) an N-methyl-D-aspartame receptor antagonist and (iii) an antipyretic agent is provided by providing a hypothermic condition. Administered to patients in an effective amount to aid neuroprotection.
priorityDate 2000-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408264951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452892474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502092

Total number of triples: 68.